ArticleOncoimmunology2016

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

Steve Boudewijns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.